Concepts (93)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stroke Rehabilitation | 3 | 2025 | 14 | 1.200 |
Why?
|
| Vaping | 2 | 2024 | 138 | 1.190 |
Why?
|
| Electronic Nicotine Delivery Systems | 3 | 2024 | 214 | 1.120 |
Why?
|
| Uterine Cervical Dysplasia | 2 | 2019 | 36 | 1.070 |
Why?
|
| Smoking Cessation | 3 | 2019 | 412 | 1.070 |
Why?
|
| Stroke | 4 | 2025 | 256 | 0.970 |
Why?
|
| Wearable Electronic Devices | 2 | 2022 | 13 | 0.920 |
Why?
|
| Binge Drinking | 1 | 2024 | 13 | 0.850 |
Why?
|
| Alcohol Drinking | 1 | 2024 | 175 | 0.750 |
Why?
|
| Tobacco, Smokeless | 1 | 2021 | 43 | 0.660 |
Why?
|
| Transcranial Direct Current Stimulation | 3 | 2025 | 16 | 0.660 |
Why?
|
| Smoking | 3 | 2024 | 476 | 0.610 |
Why?
|
| Oklahoma | 4 | 2024 | 1038 | 0.550 |
Why?
|
| Tobacco Products | 1 | 2021 | 199 | 0.550 |
Why?
|
| Adolescent | 5 | 2024 | 3165 | 0.510 |
Why?
|
| Upper Extremity | 3 | 2024 | 31 | 0.460 |
Why?
|
| Cerebral Palsy | 2 | 2020 | 30 | 0.450 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2015 | 63 | 0.420 |
Why?
|
| Tobacco Use | 1 | 2015 | 103 | 0.410 |
Why?
|
| Humans | 17 | 2025 | 28585 | 0.380 |
Why?
|
| Adult | 7 | 2025 | 7922 | 0.370 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2015 | 301 | 0.360 |
Why?
|
| Young Adult | 4 | 2024 | 2804 | 0.360 |
Why?
|
| Female | 10 | 2025 | 15472 | 0.340 |
Why?
|
| Middle Aged | 6 | 2025 | 7310 | 0.320 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2009 | 9 | 0.300 |
Why?
|
| Aged | 5 | 2025 | 5525 | 0.300 |
Why?
|
| Exercise Therapy | 1 | 2009 | 84 | 0.280 |
Why?
|
| Walking | 1 | 2009 | 135 | 0.270 |
Why?
|
| Male | 7 | 2025 | 13772 | 0.250 |
Why?
|
| Vibration | 2 | 2022 | 78 | 0.220 |
Why?
|
| California | 1 | 2024 | 70 | 0.210 |
Why?
|
| Motor Disorders | 1 | 2024 | 9 | 0.210 |
Why?
|
| Electroencephalography | 1 | 2025 | 140 | 0.210 |
Why?
|
| Cross-Sectional Studies | 2 | 2024 | 988 | 0.210 |
Why?
|
| Disease Susceptibility | 1 | 2024 | 74 | 0.210 |
Why?
|
| Pilot Projects | 2 | 2022 | 458 | 0.200 |
Why?
|
| Nicotine | 1 | 2024 | 86 | 0.200 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2023 | 100 | 0.190 |
Why?
|
| Leg | 1 | 2022 | 134 | 0.180 |
Why?
|
| Diabetic Neuropathies | 1 | 2021 | 16 | 0.170 |
Why?
|
| Quality of Life | 2 | 2022 | 504 | 0.170 |
Why?
|
| Commerce | 1 | 2021 | 54 | 0.170 |
Why?
|
| Disabled Children | 1 | 2020 | 12 | 0.170 |
Why?
|
| Disability Evaluation | 1 | 2020 | 54 | 0.160 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2020 | 7 | 0.160 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2020 | 20 | 0.160 |
Why?
|
| Early Detection of Cancer | 1 | 2021 | 132 | 0.160 |
Why?
|
| Psychometrics | 1 | 2020 | 122 | 0.160 |
Why?
|
| Schools | 1 | 2020 | 83 | 0.160 |
Why?
|
| Brain | 1 | 2025 | 753 | 0.160 |
Why?
|
| Interferon Type I | 1 | 2020 | 56 | 0.160 |
Why?
|
| Indians, North American | 1 | 2024 | 534 | 0.150 |
Why?
|
| Educational Measurement | 1 | 2020 | 131 | 0.150 |
Why?
|
| Interviews as Topic | 1 | 2019 | 160 | 0.150 |
Why?
|
| Diabetes Mellitus | 1 | 2021 | 215 | 0.140 |
Why?
|
| Autoimmunity | 1 | 2020 | 158 | 0.140 |
Why?
|
| Students | 1 | 2020 | 199 | 0.140 |
Why?
|
| Lung Neoplasms | 1 | 2021 | 357 | 0.130 |
Why?
|
| Marketing | 1 | 2015 | 35 | 0.110 |
Why?
|
| Data Collection | 1 | 2015 | 105 | 0.110 |
Why?
|
| Neoplasms | 1 | 2023 | 857 | 0.110 |
Why?
|
| Smoking Prevention | 1 | 2015 | 90 | 0.110 |
Why?
|
| United States | 2 | 2020 | 2201 | 0.110 |
Why?
|
| Longitudinal Studies | 1 | 2015 | 426 | 0.100 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 1026 | 0.090 |
Why?
|
| Aged, 80 and over | 1 | 2016 | 2045 | 0.090 |
Why?
|
| Orthotic Devices | 1 | 2009 | 7 | 0.080 |
Why?
|
| Child | 2 | 2020 | 2271 | 0.070 |
Why?
|
| Recovery of Function | 1 | 2025 | 122 | 0.060 |
Why?
|
| Motor Cortex | 1 | 2024 | 48 | 0.050 |
Why?
|
| Cross-Over Studies | 1 | 2024 | 137 | 0.050 |
Why?
|
| Amputation Stumps | 1 | 2022 | 3 | 0.050 |
Why?
|
| Tibia | 1 | 2022 | 39 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2024 | 389 | 0.050 |
Why?
|
| Pandemics | 1 | 2023 | 196 | 0.050 |
Why?
|
| Wound Healing | 1 | 2022 | 126 | 0.040 |
Why?
|
| Behavioral Risk Factor Surveillance System | 1 | 2021 | 21 | 0.040 |
Why?
|
| Sensation | 1 | 2021 | 12 | 0.040 |
Why?
|
| Postural Balance | 1 | 2021 | 41 | 0.040 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2020 | 3 | 0.040 |
Why?
|
| Interferon Regulatory Factor-7 | 1 | 2020 | 7 | 0.040 |
Why?
|
| Mass Screening | 1 | 2021 | 156 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2020 | 188 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2020 | 163 | 0.040 |
Why?
|
| Pain | 1 | 2021 | 258 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2021 | 478 | 0.040 |
Why?
|
| Blotting, Western | 1 | 2020 | 515 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2020 | 782 | 0.030 |
Why?
|
| Models, Biological | 1 | 2020 | 468 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2020 | 1602 | 0.030 |
Why?
|
| Mice | 1 | 2020 | 4735 | 0.020 |
Why?
|
| Animals | 1 | 2020 | 10583 | 0.020 |
Why?
|